Abstract | BACKGROUND:
Melanoma is highly resistant to current modalities of therapy, with the extent of pigmentation playing an important role in therapeutic resistance. Nuclear factor-κB (NF-κB) is constitutively activated in melanoma and can serve as a molecular target for cancer therapy and steroid/secosteroid action. METHODS: Cultured melanoma cells were used for mechanistic studies on NF-κB activity, utilising immunofluorescence, western blotting, EMSA, ELISA, gene reporter, and estimated DNA synthesis assays. Formalin-fixed, paraffin-embedded specimens from melanoma patients were used for immunocytochemical analysis of NF-κB activity in situ. RESULTS: Novel 20-hydroxyvitamin (20( OH)D(3)) and classical 1α,25-dihydroxyvitamin D(3) ( 1,25(OH)(2)D(3)) secosteroids inhibited melanoma cell proliferation. Active forms of vitamin D were found to inhibit NF-κB activity in nonpigmented cells, while having no effect on pigmented cells. Treatment of nonpigmented cells with vitamin D3 derivatives inhibited NF-κB DNA binding and NF-κB-dependent reporter assays, as well as inhibited the nuclear translocation of the p65 NF-κB subunit and its accumulation in the cytoplasm. Moreover, analysis of biopsies of melanoma patients showed that nonpigmented and slightly pigmented melanomas displayed higher nuclear NF-κB p65 expression than highly pigmented melanomas. CONCLUSION:
|
Authors | Z Janjetovic, A A Brozyna, R C Tuckey, T-K Kim, M N Nguyen, W Jozwicki, S R Pfeffer, L M Pfeffer, A T Slominski |
Journal | British journal of cancer
(Br J Cancer)
Vol. 105
Issue 12
Pg. 1874-84
(Dec 06 2011)
ISSN: 1532-1827 [Electronic] England |
PMID | 22095230
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- NF-kappa B
- Cholecalciferol
|
Topics |
- Cell Division
(drug effects)
- Cell Line, Tumor
- Cholecalciferol
(pharmacology)
- Humans
- Melanoma
(metabolism, pathology)
- NF-kappa B
(metabolism)
|